Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often ...

LOS ANGELES (KABC) -- Doctors know how to spot large artery blockages when someone is experiencing heart attack symptoms, but often not those in the smaller heart ...

Please provide your email address to receive an email when new articles are posted on . In patients with ischemia and no obstructive coronary arteries, known as INOCA, the level of nonobstructive ...

Please provide your email address to receive an email when new articles are posted on . Almost one-third of patients with psoriasis also had coronary microvascular dysfunction (CMD). Psoriasis ...

VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), ...

Coronary microvascular dysfunction (CMD) affects 4 million people worldwide, impacting more women than men. Despite how common this heart condition is, it is often overlooked in patients. CMD is ...

Exercise electrocardiographic (ECG) stress tests appeared to reliably indicate that some patients with angina with nonobstructive coronary arteries (ANOCA) actually had coronary microvascular ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...

Garden-variety exercise stress testing can be used in patients who have angina with nonobstructive coronary arteries (ANOCA) to uncover the presence of coronary microvascular dysfunction (CMD), new ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

Endotronix co-founder and former CEO joins VahatiCor as the company advances the A-FLUX Reducer System and the SERRA-I early feasibility study VahatiCor, Inc., a medtech company developing interventio ...